Shingles following infliximab infusion.
Baumgart
D C
DC
Dignass
A U
AU
D000212:Acyclovir / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D000998:Antiviral Agents / Q000627:therapeutic use; D003424:Crohn Disease / Q000188:drug therapy*; D005765:Gastrointestinal Agents / Q000009:adverse effects*; D006562:Herpes Zoster / Q000139:chemically induced* / Q000188:drug therapy; D006801:Humans; D000069285:Infliximab; D008297:Male; D008875:Middle Aged
D000911:Antibodies, Monoclonal; D000998:Antiviral Agents; D005765:Gastrointestinal Agents; D000069285:Infliximab; D000212:Acyclovir